Olivet, France

Frederique Touzeau


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Frederique Touzeau

Introduction

Frederique Touzeau is a notable inventor based in Olivet, France. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work with heterocyclic compounds. With 1 patent to her name, Frederique's inventions have the potential to impact the development of new medicinal products.

Latest Patents

Frederique's sole patent focuses on heterocyclic compounds, specifically a compound of formula (I). The patent details the properties and applications of this compound, which includes various substituents defined in the description, making it useful as imidazoline receptor ligands. These ligands play a crucial role in the development of therapeutics, highlighting the importance of Frederique’s innovation in medical research.

Career Highlights

Frederique Touzeau is associated with Adir Et Compagnie, where she continues to push the boundaries of medicinal chemistry. Her innovative research focuses on creating new compounds that can aid in therapeutic applications, showcasing her dedication to improving healthcare through science.

Collaborations

Working alongside esteemed colleagues such as Gerald Guillaumet and Jean-Yves Merour, Frederique thrives in a collaborative environment that fosters innovation. Their teamwork not only enhances the quality of their research but also contributes to advancements in the field of medicinal compounds.

Conclusion

Frederique Touzeau's contributions to the field of medicinal chemistry through her unique patent exemplify the spirit of innovation. Her work continues to inspire new research and discoveries, and she represents the drive and dedication found in inventors today. Her patent is a testament to the potential of heterocyclic compounds in medicinal applications, paving the way for future developments in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…